In Philadelphia this month, Editor in Chief Jonah Comstock spoke with Craig Ackerman, a partner at the Alexander Group, about ...

President Donald Trump has signed an executive order imposing tariffs of up to 100% on imported brandname medicines, unless ...

Each year, World Bipolar Day is an opportunity to raise awareness and deepen understanding of bipolar disorder, a condition ...

AZ has yet to file for approval of Imfinzi in the frontline setting for earlier-stage HCC, despite its well-established role ...

The Roivant group company said that treatment with batoclimab had shown some improvement in the eye bulging (proptosis) ...

Trump started the Section 232 probe into pharma in the spring of 2025, using it as a lever for trade negotiations and MFN ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would ...

For Lebrat, it goes back to simplicity of use: the synthetic persona leverages the data a team already has. Synthetic ...

A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

Finally, New York's Gilgamesh Pharma – a spinout company formed when AbbVie bought Gilgamesh Pharmaceuticals and its ...

In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...